Atopic dermatitis is a chronic skin inflammation that is mostly seen in infants of age 2-3 months and above to children under 5 years of age. However, there are cases of this affecting adults as well. A skin disease that lasts for long, atopic dermatitis is associated with itchiness, redness of skin and cracked skin. While the causes till date remain unknown, it is said that people who have atopic dermatitis tend to develop hay fever and asthma. Atopic dermatitis is believed to be a genetic problem. There is also a common belief that environmental conditions can make potentially susceptible individuals more likely to get atopic dermatitis. Other factors include seasonal allergies, varying humidity levels, extreme climatic conditions and reaction to strong detergents.
Apart from the growing population that is driving the growth of the atopic dermatitis treatment market, factors such as climatic changes and rising pollution levels are also fuelling the growth of this market. A significant amount of research and development efforts by research institutes and pharmaceutical companies alike is leading to the development of new drugs to deal with this condition. The use of biologics and biomarkers in the treatment of atopic dermatitis is one such development. However, time to market stemming from the approval process for new drugs coupled with high prices is inhibiting the growth of the market to a certain extent.
A common course of treatment recommended for atopic dermatitis is usually a bath with luke warm water followed by the application of a moisturizing cream or lotion. In case the symptoms worse, the application of steroid creams are the next course of action along with some medication to lessen the itchiness. Some of the medications used have known side effects and this increases the challenge for treatment of atopic dermatitis since its occurences is more in children under 5 years of age.
Of all the currently available treatments available for atopic dermatitis, topical steroids account for the largest share of the market.
In terms of type of treatment, the Atopic Dermatitis Treatment market has been segmented across the following
- Topical Corticosteroids
The market has been segmented based on the following geographies:
- North America
- South America
- Middle East
Following are just a few of the companies that are operating in the Atopic Dermatitis Treatment market:
- Pfizer Inc.
- Astellas Pharma
- Meda AB
- Regeneron Pharmaceuticals Inc
1. Atopic Dermatitis Treatment Market Overview
2. Executive Summary
3. Atopic Dermatitis Treatment Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Atopic Dermatitis Treatment Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Atopic Dermatitis Treatment Market
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Atopic Dermatitis Treatment Market Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Atopic Dermatitis Treatment Market By Type of Treatment
6.1. Topical Corticosteroids
7. Atopic Dermatitis Treatment Market By Geography
7.2. Global Study
7.3.1. North America
8. Atopic Dermatitis Treatment Market Entropy
8.1. New Product Launches
8.2. M&As, Collaborations, JVs and Partnerships
9. Company Profiles
9.2. Regeneron Pharmaceuticals Inc.
9.3. Astellas Pharma
9.4. Anacor Pharmaceuticals Inc.
9.5. Meda AB
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10.3. Research Methodology
10.5. Compilation of Expert Insights